drugset / Trial / NCT00618098

Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures

NCT00618098

Phase 3 Completed 200 enrolled Octapharma
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Octaplex (human prothrombin complex concentrate) can reverse the effects of anticoagulants when compared to the standard treatment of fresh frozen plasma (FFP).

Timeline

Start
2008-05
Primary completion
2012-03
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fresh Frozen Plasma Protein / enzyme biologic 5 ml Intravenous
Subject Octaplex Protein / enzyme biologic Intravenous

Indications

No indication recorded.